Fièvre hémorragique de Crimée-Congo : une maladie virale émergente en Europe [Crimean-Congo hemorrhagic fever : an emerging viral hemorrhagic fever in Europe]

Détails

ID Serval
serval:BIB_6B57C17E2203
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Fièvre hémorragique de Crimée-Congo : une maladie virale émergente en Europe [Crimean-Congo hemorrhagic fever : an emerging viral hemorrhagic fever in Europe]
Périodique
Revue medicale suisse
Auteur⸱e⸱s
Stavropoulou E., Troillet N.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
10/10/2018
Peer-reviewed
Oui
Volume
14
Numéro
622
Pages
1786-1789
Langue
français
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Crimean-Congo hemorrhagic fever is transmitted by Hyalomma spp ticks or exposure to blood of infected persons or animals. It is present in European regions that are frequently visited by people living in Switzerland. It is suspected in case of fever with hemorrhagic signs and confirmed by PCR or serology. Because of its severity and potential for nosocomial transmission, it should be included of the differential diagnosis of fever in returning travelers in order to rapidly implement the adequate measures : hospitalisation with isolation precautions and treatment with ribavirin. In the absence of an effective vaccine, prevention consists of barriers precautions and postexposure prophylaxis with ribavirin in case of exposure to infected blood.
Mots-clé
Animals, Antiviral Agents/therapeutic use, Europe/epidemiology, Hemorrhagic Fever Virus, Crimean-Congo, Hemorrhagic Fever, Crimean/diagnosis, Hemorrhagic Fever, Crimean/drug therapy, Hemorrhagic Fever, Crimean/epidemiology, Humans, Ribavirin/therapeutic use, Switzerland
Pubmed
Création de la notice
17/10/2018 11:20
Dernière modification de la notice
20/08/2019 15:25
Données d'usage